Document is current
Any future updates will be listed below
-
Authors
Berry, Catherine https://orcid.org/0000-0002-7446-0443
Pavot, Vincent https://orcid.org/0000-0002-7362-643X
Anosova, Natalie G.
Kishko, Michael https://orcid.org/0000-0001-5678-3583
Li, Lu
Tibbitts, Tim
Raillard, Alice
Gautheron, Sylviane https://orcid.org/0000-0002-3562-7829
Cummings, Sheila
Bangari, Dinesh S. https://orcid.org/0000-0002-9909-1146
Kar, Swagata
Atyeo, Caroline
Deng, Yixiang
Alter, Galit https://orcid.org/0000-0002-7680-9215
Gutzeit, Cindy
Koutsoukos, Marguerite https://orcid.org/0000-0002-4174-8424
Chicz, Roman M.
Lecouturier, Valerie https://orcid.org/0000-0003-1580-598X
- License Information
-
More Information
Article History
Received: 19 August 2022
Accepted: 9 May 2023
First Online: 26 May 2023
Competing interests
: C.B., V.P., N.G.A., M.K., D.H., T.T., A.R., S.G., D.S.B., R.M.C., and V.L. are employees of the Sanofi company and may hold shares. S.C. was an employee of Sanofi at the time of study conduct and currently employed with AbbVie and holds shares of Sanofi. S.K. is an employee of Bioqual and reports no conflicts. G.A. is a cofounder and serves as a consultant to SeromYx Systems Inc and has a patent pending through SeromYx Systems Inc. C.A. and G.A. were employees of Ragon Institute of MGH, MIT, and Harvard at the time of study conduct and currently employed with Moderna. Y.D. has nothing to disclose. M.Ko and C.G are employees of the GSK group of companies and report ownership of GSK shares.
